Operative treatment of acute complications of diverticular disease: primary or secondary anastomosis after sigmoid resection von Gooszen, A. W., Gooszen, H. G., Veerman, W., Van Dongen, V. M., Hermans, J., Kranenbarg, E. Klein, Tollenaar, R. A. E. M.

Volltext

Operative Treatment of Acute Complications of Diverticular Disease: Primary or Secondary Anastomosis after Sigmoid Resection von A. W. Gooszen, H. G. Gooszen, W. Veerman, V. M. Van Dongen, J. Hermans, E. Klein Kranenbarg, R. A. E. M. Tollenaar

Volltext

IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL von Kuiper, R P, Waanders, E, van der Velden, V H J, van Reijmersdal, S V, Venkatachalam, R, Scheijen, B, Sonneveld, E, van Dongen, J J M, Veerman, A J P, van Leeuwen, F N, Geurts van Kessel, A, Hoogerbrugge, P M

Volltext

Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia von Waanders, E, van der Velden, V H J, van der Schoot, C E, van Leeuwen, F N, van Reijmersdal, S V, de Haas, V, Veerman, A J, van Kessel, A Geurts, Hoogerbrugge, P M, Kuiper, R P, van Dongen, J J M

Volltext

EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols von Kalina, T, Flores-Montero, J, van der Velden, V H J, Martin-Ayuso, M, Böttcher, S, Ritgen, M, Almeida, J, Lhermitte, L, Asnafi, V, Mendonça, A, de Tute, R, Cullen, M, Sedek, L, Vidriales, M B, Pérez, J J, te Marvelde, J G, Mejstrikova, E, Hrusak, O, Szczepański, T, van Dongen, J J M, Orfao, A

Volltext

EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes von van Dongen, J J M, Lhermitte, L, Böttcher, S, Almeida, J, van der Velden, V H J, Flores-Montero, J, Rawstron, A, Asnafi, V, Lécrevisse, Q, Lucio, P, Mejstrikova, E, Szczepański, T, Kalina, T, de Tute, R, Brüggemann, M, Sedek, L, Cullen, M, Langerak, A W, Mendonça, A, Macintyre, E, Martin-Ayuso, M, Hrusak, O, Vidriales, M B, Orfao, A

Volltext

Analysis of minimal residual disease by Ig TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data von van der Velden, V H J, Cazzaniga, G, Schrauder, A, Hancock, J, Bader, P, Panzer-Grumayer, E R, Flohr, T, Sutton, R, Cave, H, Madsen, H O, Cayuela, J M, Trka, J, Eckert, C, Foroni, L, zur Stadt, U, Beldjord, K, Raff, T, van der Schoot, C E, van Dongen, J J M

Volltext

Improved flow cytometric detection of minimal residual disease in childhood acute lymphoblastic leukemia von Denys, B, van der Sluijs-Gelling, A J, Homburg, C, van der Schoot, C E, de Haas, V, Philippé, J, Pieters, R, van Dongen, J J M, van der Velden, V H J

Volltext

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reacti... von BEILLARD, E, PALLISGAARD, N, WATZINGER, F, LION, T, VAN DONGEN, J. J. M, HOKLAND, P, GABERT, J, VAN DER VELDEN, V. H. J, BI, W, DEE, R, VAN DER SCHOOT, E, DELABESSE, E, MACINTYRE, E, GOTTARDI, E, SAGLIO, G

Volltext

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in... von Gabert, J, Beillard, E, van der Velden, V H J, Bi, W, Grimwade, D, Pallisgaard, N, Barbany, G, Cazzaniga, G, Cayuela, J M, Cavé, H, Pane, F, Aerts, J L E, De Micheli, D, Thirion, X, Pradel, V, González, M, Viehmann, S, Malec, M, Saglio, G, van Dongen, J J M

Volltext

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma von Flores-Montero, J, Sanoja-Flores, L, Paiva, B, Puig, N, García-Sánchez, O, Böttcher, S, van der Velden, V H J, Pérez-Morán, J-J, Vidriales, M-B, García-Sanz, R, Jimenez, C, González, M, Martínez-López, J, Corral-Mateos, A, Grigore, G-E, Fluxá, R, Pontes, R, Caetano, J, Sedek, L, del Cañizo, M-C, Bladé, J, Lahuerta, J-J, Aguilar, C, Bárez, A, García-Mateo, A, Labrador, J, Leoz, P, Aguilera-Sanz, C, San-Miguel, J, Mateos, M-V, Durie, B, van Dongen, J J M, Orfao, A

Volltext

Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97 MRC AML12 protocol von van der Velden, V H J, van der Sluijs-Geling, A, Gibson, B E S, te Marvelde, J G, Hoogeveen, P G, Hop, W C J, Wheatley, K, Bierings, M B, Schuurhuis, G J, de Graaf, S S N, van Wering, E R, van Dongen, J J M

Volltext

Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multi... von Flohr, T, Schrauder, A, Cazzaniga, G, Panzer-Grümayer, R, van der Velden, V, Fischer, S, Stanulla, M, Basso, G, Niggli, F K, Schäfer, B W, Sutton, R, Koehler, R, Zimmermann, M, Valsecchi, M G, Gadner, H, Masera, G, Schrappe, M, van Dongen, J J M, Biondi, A, Bartram, C R

Volltext

Germline activating TYK2 mutations in pediatric patients with two primary acute lymphoblastic leukemia occurrences von Waanders, E, Scheijen, B, Jongmans, M C J, Venselaar, H, van Reijmersdal, S V, van Dijk, A H A, Pastorczak, A, Weren, R D A, van der Schoot, C E, van de Vorst, M, Sonneveld, E, Hoogerbrugge, N, van der Velden, V H J, Gruhn, B, Hoogerbrugge, P M, van Dongen, J J M, Geurts van Kessel, A, van Leeuwen, F N, Kuiper, R P

Volltext

The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells von de Vries, J F, Zwaan, C M, De Bie, M, Voerman, J S A, den Boer, M L, van Dongen, J J M, van der Velden, V H J

Volltext

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse... von Pfeifer, H., Cazzaniga, G., van der Velden, V. H. J., Cayuela, J. M., Schäfer, B., Spinelli, O., Akiki, S., Avigad, S., Bendit, I., Borg, K., Cavé, H., Elia, L., Reshmi, S. C., Gerrard, G., Hayette, S., Hermanson, M., Juh, A., Jurcek, T., Chillón, M. C., Homburg, C., Martinelli, G., Kairisto, V., Lange, T., Lion, T., Mueller, M. C., Pane, F., Rai, L., Damm-Welk, C., Sacha, T., Schnittger, S., Touloumenidou, T., Valerhaugen, H., Vandenberghe, P., Zuna, J., Serve, H., Herrmann, E., Markovic, S., Dongen, J. J. M. van, Ottmann, O. G.

Volltext

Next-generation sequencing indicates false-positive MRD results and better predicts prognosis after SCT in patients with childhood ALL von Kotrova, M, van der Velden, V H J, van Dongen, J J M, Formankova, R, Sedlacek, P, Brüggemann, M, Zuna, J, Stary, J, Trka, J, Fronkova, E

Volltext

Single-cell roadmap of human gonadal development von Garcia-Alonso, Luz, Lorenzi, Valentina, Mazzeo, Cecilia Icoresi, Alves-Lopes, João Pedro, Roberts, Kenny, Sancho-Serra, Carmen, Engelbert, Justin, Marečková, Magda, Gruhn, Wolfram H., Botting, Rachel A., Li, Tong, Crespo, Berta, van Dongen, Stijn, Kiselev, Vladimir Yu, Prigmore, Elena, Herbert, Mary, Moffett, Ashley, Chédotal, Alain, Bayraktar, Omer Ali, Surani, Azim, Haniffa, Muzlifah, Vento-Tormo, Roser

Volltext

Unleashing NK- and CD8 T cells by combining monalizumab and trastuzumab for metastatic HER2-positive breast cancer: Results of the MIMOSA trial von Geurts, V.C.M., Voorwerk, L., Balduzzi, S., Salgado, R., Van de Vijver, K., van Dongen, M.G.J., Kemper, I., Mandjes, I.A.M., Heuver, M., Sparreboom, W., Haanen, J.B.A.G., Sonke, G.S., Horlings, H.M., Kok, M.

Volltext

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects von van der Velden, V H J, Hochhaus, A, Cazzaniga, G, Szczepanski, T, Gabert, J, van Dongen, J J M

Volltext